STLAM enters the week of June 15 with a quietly deteriorating setup — the share price down 8% over the past month, insider selling clustered across the entire C-suite, and the ORTEX short score on a ten-day upward grind that deserves attention.
The most striking development is the coordinated insider activity on June 1. The CEO, CFO, Executive Chairman John Elkann, CTO, General Counsel, and multiple regional COOs all sold shares on the same day at €7.76 — a price roughly 23% above where the stock trades now. The transaction values were individually modest, ranging from roughly $22,000 to $157,000, and all carry a low significance score, suggesting these were likely structured vesting-related disposals rather than discretionary exits. Still, the breadth of participation across the leadership team — at least eight named officers selling on a single date — is a signal worth registering, particularly when the 90-day net insider position is a positive 145,479 shares at a net value of around $821,000. That net-positive figure is dominated by a share award to the COO of a regional division on June 4; strip that out and the recent direction of travel among active sellers is clear.
The ORTEX short score has been rising steadily, moving from 37.8 on June 4 to 42.4 on June 16 — a gain of nearly five points in ten sessions. That is not yet a high absolute reading, but the trajectory matters. The score ranks in the 34th percentile on a short-score-rank basis, meaning most of the universe is more heavily shorted, and the lending market reflects the same story: borrow availability is exceptionally loose, running at around 616% — meaning more than six shares are available to lend for every share already borrowed. Cost to borrow is just 0.84%, up 13% on the week but still firmly in the low-rate category. Nothing in the lending market points to squeeze risk or elevated conviction among short sellers. The short score's climb looks more like incremental sentiment erosion than a structural short build.
The valuation picture offers bulls one genuine anchor. The stock trades at a P/E of roughly 5.2x and a price-to-book of just 0.30x. EV/EBITDA is around 2.9x. These are distressed-level multiples for a company with a diversified global brand portfolio, and analysts retain a consensus buy rating — though the snapshot shows no recent target-price changes and no named upgrades or downgrades in the current data window. The ORTEX factor scores tell a more cautious story: momentum ranks near the bottom of the universe, quality is weak, and EPS surprise sits at the 45th percentile — not alarming, but not compelling. The bull case rests almost entirely on valuation reversion; the bear case is that cheap has been getting cheaper.
On the institutional side, the ownership structure reflects Stellantis's hybrid Franco-Italian-Dutch identity. Lingotto (the Agnelli family vehicle) holds 15.5% and Etablissements Peugeot Frères holds 7.7%, keeping strategic control firmly anchored. Among more active holders, Goldman Sachs trimmed its position by roughly 20 million shares as of May 12, while Citigroup and BofA added material positions in the same quarter — the largest incremental buyers in the reported window. BlackRock added modestly in early June. These are broker-dealer positions rather than pure investment conviction, so they warrant limited weight, but the net flow among financial institutions was broadly positive into Q2.
Earnings history provides a narrow reference point. The Q1 results on April 30 produced a one-day drop of 7.7%, with the stock down a further 3.4% five days later — a notably asymmetric reaction to the downside. The next event is flagged for July 30. Between now and then, the variables worth tracking are whether the short score's upward drift accelerates, how European auto peers — Renault was up 2.6% on the week while Volvo Cars B fell nearly 5% — continue to diverge from each other, and whether any analyst firms break the current silence on targets for a stock trading at one of the wider discounts to book value in the European auto complex.
See the live data behind this article on ORTEX.
Open STLAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.